JP2017533714A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017533714A5 JP2017533714A5 JP2017525392A JP2017525392A JP2017533714A5 JP 2017533714 A5 JP2017533714 A5 JP 2017533714A5 JP 2017525392 A JP2017525392 A JP 2017525392A JP 2017525392 A JP2017525392 A JP 2017525392A JP 2017533714 A5 JP2017533714 A5 JP 2017533714A5
- Authority
- JP
- Japan
- Prior art keywords
- mutation analysis
- mds
- cell
- sample
- free dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 9
- 238000004458 analytical method Methods 0.000 claims 8
- 230000035772 mutation Effects 0.000 claims 8
- 108020004414 DNA Proteins 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 238000007481 next generation sequencing Methods 0.000 claims 4
- 206010066476 Haematological malignancy Diseases 0.000 claims 3
- 208000002250 Hematologic Neoplasms Diseases 0.000 claims 3
- 238000012360 testing method Methods 0.000 claims 3
- 101001042041 Bos taurus Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial Proteins 0.000 claims 2
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims 2
- 108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 claims 2
- 108010076010 Cystathionine beta-lyase Proteins 0.000 claims 2
- 230000009946 DNA mutation Effects 0.000 claims 2
- 102100035813 E3 ubiquitin-protein ligase CBL Human genes 0.000 claims 2
- 102100039788 GTPase NRas Human genes 0.000 claims 2
- 102100038970 Histone-lysine N-methyltransferase EZH2 Human genes 0.000 claims 2
- 101000744505 Homo sapiens GTPase NRas Proteins 0.000 claims 2
- 101000882127 Homo sapiens Histone-lysine N-methyltransferase EZH2 Proteins 0.000 claims 2
- 101000960234 Homo sapiens Isocitrate dehydrogenase [NADP] cytoplasmic Proteins 0.000 claims 2
- 101000599886 Homo sapiens Isocitrate dehydrogenase [NADP], mitochondrial Proteins 0.000 claims 2
- 101000653374 Homo sapiens Methylcytosine dioxygenase TET2 Proteins 0.000 claims 2
- 101000728236 Homo sapiens Polycomb group protein ASXL1 Proteins 0.000 claims 2
- 101000587430 Homo sapiens Serine/arginine-rich splicing factor 2 Proteins 0.000 claims 2
- 101000707567 Homo sapiens Splicing factor 3B subunit 1 Proteins 0.000 claims 2
- 101000808799 Homo sapiens Splicing factor U2AF 35 kDa subunit Proteins 0.000 claims 2
- 101000813738 Homo sapiens Transcription factor ETV6 Proteins 0.000 claims 2
- 101000658084 Homo sapiens U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 Proteins 0.000 claims 2
- 102100039905 Isocitrate dehydrogenase [NADP] cytoplasmic Human genes 0.000 claims 2
- 102100037845 Isocitrate dehydrogenase [NADP], mitochondrial Human genes 0.000 claims 2
- 102100030803 Methylcytosine dioxygenase TET2 Human genes 0.000 claims 2
- 102100029799 Polycomb group protein ASXL1 Human genes 0.000 claims 2
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 claims 2
- 102100029666 Serine/arginine-rich splicing factor 2 Human genes 0.000 claims 2
- 102100031711 Splicing factor 3B subunit 1 Human genes 0.000 claims 2
- 102100038501 Splicing factor U2AF 35 kDa subunit Human genes 0.000 claims 2
- 102100039580 Transcription factor ETV6 Human genes 0.000 claims 2
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 claims 2
- 102100035036 U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 Human genes 0.000 claims 2
- 210000005259 peripheral blood Anatomy 0.000 claims 2
- 239000011886 peripheral blood Substances 0.000 claims 2
- 210000002381 plasma Anatomy 0.000 claims 2
- 238000003752 polymerase chain reaction Methods 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 201000000050 myeloid neoplasm Diseases 0.000 claims 1
- 238000010998 test method Methods 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462078921P | 2014-11-12 | 2014-11-12 | |
| US62/078,921 | 2014-11-12 | ||
| US201462083432P | 2014-11-24 | 2014-11-24 | |
| US62/083,432 | 2014-11-24 | ||
| US14/937,937 US10604801B2 (en) | 2014-11-12 | 2015-11-11 | Deep sequecing of peripheral blood plasma DNA as a reliable test for confirming the diagnosis of myelodysplastic syndrome |
| PCT/US2015/060061 WO2016077408A1 (en) | 2014-11-12 | 2015-11-11 | Deep sequencing of peripheral blood plasma dna is reliable for confirming the diagnosis of myelodysplastic syndrome |
| US14/937,937 | 2015-11-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017533714A JP2017533714A (ja) | 2017-11-16 |
| JP2017533714A5 true JP2017533714A5 (enExample) | 2018-12-13 |
Family
ID=55911759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017525392A Pending JP2017533714A (ja) | 2014-11-12 | 2015-11-11 | 末梢血血漿ｄｎａのディープシーケンシングは、骨髄異形成症候群の診断を確認するうえで信頼性が高い |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10604801B2 (enExample) |
| EP (1) | EP3218520B1 (enExample) |
| JP (1) | JP2017533714A (enExample) |
| CN (1) | CN107002131B (enExample) |
| AU (1) | AU2015346487B2 (enExample) |
| WO (1) | WO2016077408A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700045353A1 (it) * | 2017-04-26 | 2018-10-26 | Bioscience Services S R L | Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi |
| CN108251527A (zh) * | 2017-12-29 | 2018-07-06 | 天津协和华美医学诊断技术有限公司 | 一种检测淋巴瘤相关基因群的检测试剂盒 |
| KR102080161B1 (ko) * | 2018-02-01 | 2020-02-21 | 사회복지법인 삼성생명공익재단 | 개인 맞춤형 의료를 위한 유전자 패널, 그를 구성하는 방법, 및 그를 이용한 개인 맞춤형 치료 방법 |
| EP4055187B1 (en) * | 2019-11-06 | 2025-08-20 | The Board of Trustees of the Leland Stanford Junior University | Methods for analyzing nucleic acid molecules |
| WO2022186673A1 (ko) * | 2021-03-05 | 2022-09-09 | 전남대학교산학협력단 | 차세대 염기서열분석 기반 표적유전자 rna 염기서열 분석 패널 및 분석알고리즘 |
| CN113764038B (zh) * | 2021-08-31 | 2023-08-22 | 华南理工大学 | 构建骨髓增生异常综合征转白基因预测模型的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1814792A (zh) * | 2005-02-02 | 2006-08-09 | 苏州大学附属第一医院 | 实时定量pcr检测人ddit3转录本试剂盒 |
| EP2534261B1 (en) * | 2010-02-12 | 2016-11-30 | QIAGEN Marseille | Asxl1 as a new diagnostic marker of myeloid neoplasms |
| AU2012271386A1 (en) * | 2011-06-17 | 2014-01-16 | Dana-Farber Cancer Institute, Inc. | Mutation signatures for predicting the survivability of Myelodysplastic Syndrome subjects |
| WO2013159035A2 (en) * | 2012-04-19 | 2013-10-24 | Medical College Of Wisconsin, Inc. | Highly sensitive surveillance using detection of cell free dna |
| CN103451314A (zh) * | 2013-09-30 | 2013-12-18 | 南京艾迪康医学检验所有限公司 | 检测idh1、idh2基因多态突变位点的引物、方法和试剂盒 |
-
2015
- 2015-11-11 JP JP2017525392A patent/JP2017533714A/ja active Pending
- 2015-11-11 AU AU2015346487A patent/AU2015346487B2/en active Active
- 2015-11-11 EP EP15858705.5A patent/EP3218520B1/en active Active
- 2015-11-11 WO PCT/US2015/060061 patent/WO2016077408A1/en not_active Ceased
- 2015-11-11 CN CN201580061352.0A patent/CN107002131B/zh active Active
- 2015-11-11 US US14/937,937 patent/US10604801B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017533714A5 (enExample) | ||
| Stewart et al. | The value of cell‐free DNA for molecular pathology | |
| JP2013063072A5 (enExample) | ||
| Devonshire et al. | Highly reproducible absolute quantification of Mycobacterium tuberculosis complex by digital PCR | |
| Kohl et al. | Whole-genome-based Mycobacterium tuberculosis surveillance: a standardized, portable, and expandable approach | |
| JP2015091262A5 (enExample) | ||
| JP2014518069A5 (enExample) | ||
| WO2014151764A3 (en) | Methods and compositions for classification of samples | |
| JP2014223088A5 (enExample) | ||
| EP2527471A3 (en) | Diagnosing cancer using genomic sequencing | |
| WO2013062515A3 (en) | Lung cancer biomarkers and uses thereof | |
| EP4321627A3 (en) | Spatially distinguished, multiplex nucleic acid analysis of biological specimens | |
| JP2014204730A5 (enExample) | ||
| MX350533B (es) | Biomarcadores de cancer pancreatico y usos de los mismos. | |
| WO2011071923A3 (en) | Multi-sample indexing for multiplex genotyping | |
| Desikan et al. | Genetic markers, genotyping methods & next generation sequencing in Mycobacterium tuberculosis | |
| NZ598166A (en) | Methods, primers, probes and kits useful for the detection of braf mutations | |
| JP2017532980A5 (enExample) | ||
| JP2018513679A5 (enExample) | ||
| WO2009149026A3 (en) | Genomic approaches to fetal treatment and diagnosis | |
| JP2025513786A (ja) | 無細胞核酸分子のメチル化状態に基づいた腫瘍の存在の検出 | |
| MX377788B (es) | Composiciones y metodos para la deteccion y analisis de tuberculosis micobacteriana. | |
| Cuscó et al. | Using MinION™ to characterize dog skin microbiota through full-length 16S rRNA gene sequencing approach | |
| WO2015023503A3 (en) | Compositions and methods for multimodal analysis of cmet nucleic acids | |
| JP2012050391A5 (enExample) |